OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants.
OxyPrem has raised $3.2M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in August 2024.
OxyPrem's investors include European Innovation Council, Venture Kick, MassChallenge, Capital Cell.
OxyPrem is headquartered in Zürich, Switzerland.
OxyPrem is an advanced oxygen sensor that continuously monitors oxygen levels in the brains of high-risk preterm infants.
OxyPrem is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OxyPrem — Funding & Investors." VCBacked, August 30, 2024, https://www.vcbacked.co/company/oxyprem. Accessed November 13, 2026.
VCBacked. (2024). OxyPrem — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/oxyprem
{{cite web |title=OxyPrem — Funding & Investors |url=https://www.vcbacked.co/company/oxyprem |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at OxyPrem? Request a listing update